General Clinical Research Center
General Clinical Research Center
批准号:
6809196
负责人:
JOSEPH F SILVA
金额:
$60.0万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2009-03-31
中文摘要
加州大学戴维斯分校(UC Davis)与北加州退伍军人事务部(VANCHCS)合作,提议建立一个综合临床研究中心,提供一个集中的基础设施,以支持临床/转化性研究,并扩大临床研究培训和职业发展计划。加州大学戴维斯分校处于有利地位,可以实施这一雄心勃勃的计划;主要资源已经分配给临床研究,作为创建充满活力和活力的临床研究社区的重点五年计划的一部分。加州大学戴维斯分校从多所大学招聘了经验丰富的临床研究人员,目前正在招聘一名负责临床研究的新助理院长,学院领导层完全致力于GCRC的成功。指定的7500平方英尺的GCRC单元是新建的萨克拉门托VA医疗中心的一部分,VANCHCS和加州大学戴维斯分校
为开发这一设施提供了资源。加州大学戴维斯分校和VANCHCS已经提供了超过350万美元来创建GCRC。其中,250万美元是建造GCRC设施的费用,100万美元是对开发阶段的支助。因此,GCRC的基础设施已经到位,GCRC领导人已经确定。加州大学戴维斯分校赞助研究的快速增长以及对临床和
翻译研究使拟议的GCRC成为实现加州大学戴维斯分校和VANCHCS的雄心勃勃的目标的必要和必要的组成部分,该目标是创建拥有大量研究人员的尖端临床研究企业。提交的63个方案涉及住院、门诊、实验室、生物统计学、营养学、患者安全和信息学
支持以患者为中心的研究。他们代表了广泛的调查人员和研究领域。反映加州大学戴维斯分校的科学实力,大多数方案是由四个领先的、定义广泛的和包容性的焦点领域的研究人员开发的:传染病、癌症、血管生物学/代谢和神经科学。加州大学戴维斯分校卫生系统领导层已将这些领域确定为
未来的研究增长。除了这些领域,GCRC还促进了与代表基础科学、所有领先临床中心以及医学院以外领域(如营养和工程)的研究人员在校园范围内的合作。我们将继续为来自各个领域的临床研究人员提供便利和帮助。指导和教育计划是GCRC的首要任务,并将成为扩大和集中加州大学戴维斯分校已有的许多现有资源和倡议的关键催化剂。我们致力于以患者为中心的研究,在患者护理、伦理道德、科学严谨、安全和法规遵从性方面达到最高标准,而GCRC是实现这些目标的重要组成部分。
英文摘要
The University of California Davis (UC Davis) in collaboration with the Veterans Affairs Northern California Health Care System (VANCHCS) proposes a General Clinical Research Center to provide a centralized infrastructure to support clinical/translational research and to expand clinical research training and career development programs. UC Davis is well positioned to undertake this ambitious proposal; major resources are already allocated to clinical research as part of a focused five-year plan to create a vibrant and dynamic clinical research community. UC Davis has recruited experienced clinical researchers from a multitude of universities, is currently recruiting a new Assistant Dean for Clinical Research, and the leadership of the school is fully committed to the success of the GCRC. A designated 7,500 square feet GCRC unit is a part of the newly constructed Sacramento VA Medical Center, and VANCHCS and UC Davis have
provided resources to develop this facility. UC Davis and the VANCHCS have provided more than $3.5 million to create the GCRC. Of this amount, $2.5 million represent cost for construction of the GCRC facility, and $1 million represents support for the development phase. Thus, the infrastructure for the GCRC is already in place, and GCRC leaders have been identified. The rapid growth in sponsored research at UC Davis together with the strategic focus on clinical and
translational research makes the proposed GCRC a necessary and essential component to achieve the ambitious goals of UC Davis and VANCHCS to create a cutting edge clinical research enterprise with a critical mass of investigators. The 63 submitted protocols use inpatient, outpatient, laboratory, biostatistical, nutrition, patient safety and informatics
support for patient-oriented research. They represent a wide spectrum of investigators and research areas. Reflecting the scientific strengths at UC Davis, the majority of the protocols have been developed by investigators in four leading, broadly defined and inclusive focus areas; Infectious Disease, Cancer, Vascular Biology/Metabolism, and Neuroscience. These areas have been identified by the UC Davis Health System leadership as principal areas for
future research growth. Beyond these areas, the GCRC has fostered campus-wide collaborations with investigators representing basic sciences, all the leading clinical centers, and areas outside the medical school such as nutrition and engineering. We will continue to facilitate and assist clinical researchers from all areas. Mentoring and education plans are a top priority of the GCRC, and will serve as a critical catalyst to expand and focus the many existing resources and initiatives already in place at UC Davis. We aspire to perform patient-oriented research with the highest standards of patient care, ethics, scientific rigor, safety and regulatory compliance, and the GCRC is an essential component to achieve these goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II TRIAL OF G3139 ANTI-BCL-2 OLIGONUCLEOTIDE PLUS A-INTERFERON IN METASTA
-
批准号:6975662
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2004
-
负责人:JOSEPH F SILVA
-
依托单位:
General Clinical Research Center
-
批准号:6952372
-
项目类别:
-
资助金额:$134.17万
-
财政年份:2004
-
负责人:JOSEPH F SILVA
-
依托单位:
HISPANIC CENTERS OF EXCELLENCE
-
批准号:2433916
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:JOSEPH F SILVA
-
依托单位:
HISPANIC CENTERS OF EXCELLENCE
-
批准号:2239066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:JOSEPH F SILVA
-
依托单位:
海外基金